Population Health Sciences

You are here

Publications

Found 400 results
Author Title [ Type(Desc)] Year
Filters: First Letter Of Last Name is S  [Clear All Filters]
Journal Article
Hajifathalian K, Kumar S, Newberry C, Shah S, Fortune B, Krisko T, Ortiz-Pujols S, Zhou XKathy, Dannenberg AJ, Kumar R et al..  2020.  Obesity is associated with worse outcomes in COVID-19: Analysis of Early Data From New York City.. Obesity (Silver Spring).
Hajifathalian K, Kumar S, Newberry C, Shah S, Fortune B, Krisko T, Ortiz-Pujols S, Zhou XKathy, Dannenberg AJ, Kumar R et al..  2020.  Obesity is associated with worse outcomes in COVID-19: Analysis of Early Data From New York City.. Obesity (Silver Spring).
Greenlee H, Shi Z, Hibshoosh H, Giri DD, Ahmed A, Williams S, Falcone DJ, Winston LA, Zhou XK, Hudis CA et al..  2019.  Obesity-associated Breast Inflammation among Hispanic/Latina Breast Cancer Patients.. Cancer Prev Res (Phila). 12(1):21-30.
Turchioe MReading, Grossman LV, Baik D, Lee CS, Maurer MS, Goyal P, Safford MM, Creber RMMasterso.  2020.  Older Adults Can Successfully Monitor Symptoms Using an Inclusively Designed Mobile Application.. J Am Geriatr Soc.
Aviki EM, Schleicher SM, Mullangi S.  2019.  The Oncology Care Model and Other Value-Based Payment Models in Cancer Care.. JAMA Oncol. 5(3):298-299.
Mones E, Stopczynski A, Pentland A'Sandy', Hupert N, Lehmann S.  2018.  Optimizing targeted vaccination across cyber-physical networks: an empirically based mathematical simulation study.. J R Soc Interface. 15(138)
Glass HC, Grinspan ZM, Shellhaas RA.  2018.  Outcomes after acute symptomatic seizures in neonates.. Semin Fetal Neonatal Med. 23(3):218-222.
Morgan JR, Schackman BR, Weinstein ZM, Walley AY, Linas BP.  2019.  Overdose following initiation of naltrexone and buprenorphine medication treatment for opioid use disorder in a United States commercially insured cohort.. Drug Alcohol Depend. 200:34-39.
McHugh M, Shi Y, Ramsay PP, Harvey JB, Casalino LP, Shortell SM, Alexander JA.  2016.  Patient-Centered Medical Home Adoption: Results From Aligning Forces For Quality.. Health Aff (Millwood). 35(1):141-9.
McHugh M, Shi Y, Ramsay PP, Harvey JB, Casalino LP, Shortell SM, Alexander JA.  2016.  Patient-Centered Medical Home Adoption: Results From Aligning Forces For Quality.. Health Aff (Millwood). 35(1):141-9.
Vest JR, Kern LM, Jung H-Y, Ancker JS, Richardson JE, Silver MD, Kaushal R.  2015.  Patient-centered medical homes: observable types derived from national recognition assessment scores.. J Ambul Care Manage. 38(2):144-52.
Kern LM, Grinspan Z, Shapiro JS, Kaushal R.  2017.  Patients' Use of Multiple Hospitals in a Major US City: Implications for Population Management.. Popul Health Manag. 20(2):99-102.
Hearld LR, Alexander JA, Shi Y, Casalino LP.  2014.  Pay-for-performance and public reporting program participation and administrative challenges among small- and medium-sized physician practices.. Med Care Res Rev. 71(3):299-312.
Batra JS, Niaz MJunaid, Whang YE, Sheikh A, Thomas C, Christos P, Vallabhajosula S, Jhanwar YS, Molina AM, Nanus DM et al..  2020.  Phase I trial of docetaxel plus lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 (Lu-J591) for metastatic castration-resistant prostate cancer.. Urol Oncol.
Beltran H, Oromendia C, Danila DC, Montgomery B, Hoimes C, Szmulewitz RZ, Vaishampayan U, Armstrong AJ, Stein M, Pinski J et al..  2019.  A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers.. Clin Cancer Res. 25(1):43-51.
Beltran H, Oromendia C, Danila DC, Montgomery B, Hoimes C, Szmulewitz RZ, Vaishampayan U, Armstrong AJ, Stein M, Pinski J et al..  2019.  A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers.. Clin Cancer Res. 25(1):43-51.
Beltran H, Oromendia C, Danila DC, Montgomery B, Hoimes C, Szmulewitz RZ, Vaishampayan U, Armstrong AJ, Stein M, Pinski J et al..  2019.  A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers.. Clin Cancer Res. 25(1):43-51.
Beltran H, Oromendia C, Danila DC, Montgomery B, Hoimes C, Szmulewitz RZ, Vaishampayan U, Armstrong AJ, Stein M, Pinski J et al..  2019.  A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers.. Clin Cancer Res. 25(1):43-51.
Beltran H, Oromendia C, Danila DC, Montgomery B, Hoimes C, Szmulewitz RZ, Vaishampayan U, Armstrong AJ, Stein M, Pinski J et al..  2019.  A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers.. Clin Cancer Res. 25(1):43-51.
Casalino LP, Pesko MF, Ryan AM, Nyweide DJ, Iwashyna TJ, Sun X, Mendelsohn J, Moody J.  2015.  Physician Networks and Ambulatory Care-sensitive Admissions.. Med Care. 53(6):534-41.
Shortell SM, McClellan SR, Ramsay PP, Casalino LP, Ryan AM, Copeland KR.  2014.  Physician practice participation in accountable care organizations: the emergence of the unicorn.. Health Serv Res. 49(5):1519-36.
Richardson JE, Kern LM, Silver M, Jung H-Y, Kaushal R.  2016.  Physician Satisfaction in Practices That Transformed Into Patient-Centered Medical Homes: A Statewide Study in New York.. Am J Med Qual. 31(4):331-6.
Gupta A, Kesavabhotla K, Baradaran H, Kamel H, Pandya A, Giambrone AE, Wright D, Pain KJ, Mtui EE, Suri JS et al..  2015.  Plaque echolucency and stroke risk in asymptomatic carotid stenosis: a systematic review and meta-analysis.. Stroke. 46(1):91-7.
Gupta A, Kesavabhotla K, Baradaran H, Kamel H, Pandya A, Giambrone AE, Wright D, Pain KJ, Mtui EE, Suri JS et al..  2015.  Plaque echolucency and stroke risk in asymptomatic carotid stenosis: a systematic review and meta-analysis.. Stroke. 46(1):91-7.
Press MJ, Gerber LM, Peng TR, Pesko MF, Feldman PH, Ouchida K, Sridharan S, Bao Y, Barron Y, Casalino LP.  2015.  Post-Discharge Communication Between Home Health Nurses and Physicians: Measurement, Quality, and Outcomes.. J Am Geriatr Soc. 63(7):1299-305.